Hepatitis B surface antigen (HBsAg) prevalence in Norway
Norway: Hepatitis B surface antigen (HBsAg) prevalence was 0.0% in 2024. ◆ Volatile
Latest (2024)
0.0%
World rank
132nd
of 194 countries
All-time high
0.1%
in 2015
All-time low
0.0%
in 2020
Years of data
10
2015–2024
Hepatitis B surface antigen (HBsAg) prevalence in Norway, 2015–2024
Source: World Health Organization, Global Health Observatory.
Analysis
Norway recorded 0.0% for hepatitis b surface antigen (hbsag) prevalence in 2024. That is the lowest value across all 10 years on record.
The figure is down 100.0% over ten years.
Over the whole period, hepatitis b surface antigen (hbsag) prevalence in Norway peaked at 0.1% in 2015 and was at its lowest, 0.0%, in 2020.
That places Norway 132nd out of 194 countries with data for 2024, putting it in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 0.1% | 0.1% | 0.1% | 5 |
| 2020s | 0.0% | 0.0% | 0.0% | 5 |
Countries ranked near Norway
- 132 Saudi Arabia 0.0%
- 132 El Salvador 0.0%
- 132 San Marino 0.0%
- 132 Slovak Republic 0.0%
- 132 Slovenia 0.0% compare
- 132 Sweden 0.0%
- 132 Türkiye 0.0% compare
- 132 Uruguay 0.0%
- 132 United States 0.0%
- 132 Andorra 0.0%
- 132 United Arab Emirates 0.0%
- 132 Argentina 0.0%
- 132 Austria 0.0%
- 132 Belgium 0.0%
- 132 Bulgaria 0.0% compare
- 132 Bahrain 0.0%
- 132 Belarus 0.0%
- 132 Brazil 0.0%
- 132 Canada 0.0%
- 132 Switzerland 0.0% compare
- 132 Chile 0.0%
- 132 Cook Islands 0.0%
- 132 Colombia 0.0%
- 132 Costa Rica 0.0%
- 132 Cuba 0.0%
- 132 Czechia 0.0%
- 132 Germany 0.0%
- 132 Ecuador 0.0%
- 132 Egypt 0.0% compare
- 132 Spain 0.0%
- 132 Estonia 0.0%
- 132 Finland 0.0%
- 132 France 0.0%
- 132 United Kingdom 0.0% compare
- 132 Georgia 0.0%
- 132 Greece 0.0%
- 132 Guatemala 0.0% compare
- 132 Honduras 0.0%
- 132 Croatia 0.0%
- 132 Ireland 0.0%
- 132 Iran 0.0%
- 132 Iceland 0.0% compare
- 132 Italy 0.0%
- 132 Japan 0.0% compare
- 132 Korea 0.0% compare
- 132 Kuwait 0.0%
- 132 Luxembourg 0.0%
- 132 Latvia 0.0% compare
- 132 Morocco 0.0%
- 132 Monaco 0.0%
- 132 Mexico 0.0%
- 132 Malta 0.0% compare
- 132 Montenegro 0.0%
- 132 Nicaragua 0.0% compare
- 132 Niue 0.0%
- 132 Netherlands 0.0%
- 132 New Zealand 0.0% compare
- 132 Panama 0.0%
- 132 Poland 0.0%
- 132 Portugal 0.0%
- 132 Palestine, State of 0.0% compare
- 132 Qatar 0.0% compare
More health data for Norway
- Un projection of annual infant deaths, annual growth rate -7.69 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.337 % change on previous year (2090)
- Heat deaths vs projected death rates 1,212 (2090)
- Un projection of annual infant deaths 12 (2100)
- Population ages 65 and above, total, annual growth rate 2.27 % change on previous year (2025)
- Population ages 65 and above, total, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 65 and above, total, per capita 0.1908 units per person (2025)
- Population, female, annual growth rate 0.6722 % change on previous year (2025)
- Population, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population, female, per capita 0.4959 units per person (2025)
Frequently asked questions
- What is hepatitis b surface antigen (hbsag) prevalence in Norway?
- Hepatitis b surface antigen (hbsag) prevalence in Norway was 0.0% in 2024, according to World Health Organization, Global Health Observatory.
- What is the highest hepatitis b surface antigen (hbsag) prevalence recorded in Norway?
- The highest recorded value was 0.1% in 2015.
- What is the lowest hepatitis b surface antigen (hbsag) prevalence recorded in Norway?
- The lowest recorded value was 0.0% in 2020.
- How does Norway rank for hepatitis b surface antigen (hbsag) prevalence?
- Norway ranks 132nd out of 194 countries with data for 2024.
- Is hepatitis b surface antigen (hbsag) prevalence rising or falling in Norway?
- Over the last ten years it is down 100.0%. The long-run trend across the full record is volatile.
- Where does this Norway data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).